CAS Number919077-81-9
Synonymsnor-Binaltorphimine dihydrochloride; HMS3269N05; N-Cyclohexyl-1-(2,4-dichlorophenyl)-6-methyl-1,4-dihydroindeno[1,2-c]pyrazole-3-carboxamide; GP 2A
Molecular FormulaC24H23Cl2N3O
Molecular Weight440.365
Density1.4±0.1 g/cm3
Boiling Point632.9±55.0 °C at 760 mmHg
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 919077-81-9 |
| Catalog No. | 2A-1170332 |
| Chinese Name | CB2 receptor agonist 3 |
| Synonyms | nor-Binaltorphimine dihydrochloride; HMS3269N05; N-Cyclohexyl-1-(2,4-dichlorophenyl)-6-methyl-1,4-dihydroindeno[1,2-c]pyrazole-3-carboxamide; GP 2A |
| Molecular Formula | C24H23Cl2N3O |
| Molecular Weight | 440.365 |
| Density | 1.4±0.1 g/cm3 |
| Boiling Point | 632.9±55.0 °C at 760 mmHg |
| Application | CB2 receptor agonist 3 is a robust and selective CB2 cannabinoid agonist with Kis of 7.6 and 900 nM for CB2 and CB1, respectively. CB2 receptor agonist 3 significantly increases the expression of P-ER |
| PubChem ID | 24741145 |
| SMILES | Cc1ccc2c(c1)Cc1c(C(=O)NC3CCCCC3)nn(-c3ccc(Cl)cc3Cl)c1-2 |
| InChI | InChI=1S/C24H23Cl2N3O/c1-14-7-9-18-15(11-14)12-19-22(24(30)27-17-5-3-2-4-6-17)28-29(23(18)19)21-10-8-16(25)13-20(21)26/h7-11,13,17H,2-6,12H2,1H3,(H,27,30) |
| InChI Key | SPEFJYZGXZENAF-UHFFFAOYSA-N |
| Transport Info | Product name: CB2 receptor agonist 3 |
| Related Products in Specialty Chemicals | ||
|---|---|---|
| PLX647 | 873786-09-5 | 2A-1170326 |
| STK321130 | 923562-23-6 | 2A-1170327 |
| (3-Chlorophenyl)[3,4-dihydro-6,7-dimethoxy-1-[(4-methoxyphenoxy)methyl]-2(1H)-isoquinolinyl]methanone | 486427-17-2 | 2A-1170328 |
| PLX3397 (Pexidartinib) | 1029044-16-3 | 2A-1170329 |
| BMS-687453 | 1000998-59-3 | 2A-1170330 |
| AI-10-49 | 1256094-72-0 | 2A-1170333 |
| 4-Benzyl-2-(naphthalen-1-yl)-[1,2,4]thiadiazolidine-3,5-dione | 865854-05-3 | 2A-1170336 |
| GW 627368X | 439288-66-1 | 2A-1170337 |
| LY 2874455 | 1254473-64-7 | 2A-1170341 |
| LY 2784544 | 1229236-86-5 | 2A-1170342 |
| Browse all Specialty Chemicals products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA
EN
SDS